Lot Numbers and Traceability in Peptide Research Labs

Six months into a project, a cell-migration assay that behaved for weeks starts drifting. The cells, media and plates have not changed. The question that settles the matter in five minutes, or leaves it open for five weeks, is simple: which lot of peptide went into each plate? Lot numbers and traceability are unglamorous, but they are what let a lab separate reagent variation from biology. This article explains what a lot is, where lot-to-lot differences come from, how to build a traceability chain from vial to dataset, and how it applies to a peptide such as TB-500.

What a lot number actually identifies

A lot, or batch, is a defined quantity of material made in one production run and tested as a unit. For a synthetic peptide that usually means a single synthesis, cleavage, purification and lyophilization sequence, filled into vials that all carry the same identifier. The lot number is the key that connects a physical vial to:

• the certificate of analysis for that lot (purity, identity, often content);
• the manufacturing record of synthesis and purification conditions;
• any retained sample kept for later re-testing;
• distribution records showing where vials were shipped.

Lot number formats vary. Many encode the product, the year or date of manufacture and a sequence number; others are opaque codes. The format matters less than consistency: the same identifier should appear on the vial, the outer packaging, the certificate and the invoice. Watch for sub-lots, where one large purified batch is lyophilized or filled in several runs. Those fills can differ slightly in water content and should carry their own suffix or certificate. A retest or expiry date on the label is another sign that the manufacturer tracks the lot over time rather than only at release.

Quality systems for pharmaceutical peptides treat these links as mandatory, with specifications for identity, purity and assay applied lot by lot [2]. Research reagents are held to lighter formal rules, but the same logic makes their data interpretable. A certificate is only meaningful if it belongs to the lot in your freezer; see how to read a peptide certificate of analysis.

Why lot-to-lot variability happens

Two lots can both pass a 98% purity specification and still differ in ways that matter:

• Impurity profile. The remaining 2% may be different deletion sequences or diastereomers in each lot, with different biological activity.
• Counterion and water content. TFA, acetate and bound water vary with purification and drying, changing net peptide content.
• Net peptide content. If one lot is 80% peptide by weight and the next is 68%, identical weighing gives a 15% difference in actual concentration.
• Storage history. Degradation after manufacture, from moisture or warm transit, differs vial to vial.

Independent re-testing has shown how wide real-world variation can be. In one evaluation of commercially synthesized research peptides, fewer than half met the purity requested, and one main component had the wrong structure [3]. Without lot numbers, such a finding cannot be traced to specific material or specific experiments.

The cost of losing the chain

Reagent problems are a recognized driver of irreproducible research. An economic analysis of preclinical studies estimated that irreproducibility costs about US$28 billion a year in the United States and named biological reagents and reference materials among the major contributors [1]. Antibody researchers reached a similar conclusion about poorly defined reagents and argued for sequence-defined, well-documented materials [5]. Peptides are chemically defined, which is an advantage, but only if each lot's identity and quality are documented and followed through to the data.

Lot numbers and traceability: building the chain

A practical chain has five links:

1. Receiving. Log the lot number, quantity, receipt date, condition on arrival and certificate reference. File the certificate where the notebook can point to it.
2. Storage. Record freezer and position. Note any temperature excursions.
3. Preparation. When a stock is made, record lot, solvent, solvent lot, concentration basis (gross weight or net peptide content) and date.
4. Aliquots. Label each tube with peptide name, lot, concentration and date. A short code linking to the notebook entry works well.
5. Experiments. Record the aliquot and lot in every experiment's metadata, alongside cell passage and media lot.

Electronic lab notebooks or a simple LIMS make this easier, but a disciplined spreadsheet works. The aim is that any data point can be traced back to one vial in under a minute.

Switching lots without breaking an experiment

When a lot runs out mid-project:

• Buy ahead. For long studies, reserve enough of a single lot to finish, and store it properly (see lyophilized peptide storage).
• Bridge before switching. Run old and new lots side by side in the same assay and compare against predefined acceptance limits.
• Normalize by content. Prepare stocks from net peptide content so concentration is comparable across lots.
• Record the switch. Mark in the dataset exactly where the new lot enters.

Example: traceability for TB-500

TB-500 shows why lot-level identity matters. Analytical work on commercial TB-500 identified its key component as the N-terminally acetylated heptapeptide Ac-LKKTETQ, corresponding to residues 17-23 of thymosin beta-4, and confirmed it against a synthesized reference by LC-high-resolution MS [4]. The name has also been used loosely for full-length thymosin beta-4, a 43-residue protein of roughly 4.9 kDa.

For a lab working with TB-500, the lot certificate should therefore show a mass consistent with the intended molecule, for example [M+2H]2+ near m/z 445.25 for Ac-LKKTETQ (monoisotopic mass 888.49 Da). If a later lot's spectrum pointed to a different mass, lot records are what reveal which experiments used which material. Our article on mass spectrometry and peptide identity explains how to read those spectra, and per-lot data are posted on our lab reports page.

When something looks wrong

If a lot is suspected of causing a problem:

1. Stop using it and quarantine the remaining vials and aliquots.
2. Pull the lot certificate and compare it with previous lots.
3. Re-test a retained aliquot by HPLC and MS if possible.
4. Contact the supplier with the lot number and your observations; ask whether other reports exist for that lot.
5. Use your records to identify every experiment that used the lot, and flag them for review.

Key takeaways

• A lot number ties a physical vial to its certificate, manufacturing record and retained samples.
• Lots meeting the same purity specification can still differ in impurity profile, salt content and net peptide content.
• Traceability runs from receiving through storage, stock preparation, aliquots and every experiment.
• Bridge old and new lots before switching, and prepare stocks from net peptide content.
• For peptides with loosely used names, such as TB-500, lot-level mass data confirm which molecule was used.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165. PubMed
2. Vergote V, Burvenich C, Van de Wiele C, et al. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. PubMed
3. Verbeke F, Wynendaele E, Braet S, et al. Quality evaluation of synthetic quorum sensing peptides used in R&D. J Pharm Anal. 2015;5(3):169-181. PubMed
4. Esposito S, Deventer K, Goeman J, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738. PubMed
5. Bradbury A, Pluckthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518(7537):27-29. PubMed